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Abstract
Thyroid hormones stimulate aerobic metabolism which may lead to oxidative stress accompanied by damage to vari-
ous cellular macromolecules, including DNA. Previous comet assay studies have shown that thyroid hormones
cause DNA damage due to the creation of reactive oxygen species (ROS). However, cytogenetic studies have been
equivocal because although an increase in the sister-chromatid exchange frequency per cell has been reported in-
creased micronuclei frequency has not. We used cytogenetic examination of chromosome breakage and aberrations
in whole-blood cultures of human peripheral blood lymphocytes to investigate possible clastogenic effects when lym-
phocytes were exposed to 0.002 μM to 50 μM of L-thyroxine for 24 h and 48 h, these concentrations being chosen
because they had been used in previous studies of sister-chromatid exchange and micronuclei frequency. Under our
experimental conditions thyroxine did not induced any statistically significant increase in chromosome breakage or
aberrations. This lack of clastogenic effects is in contrast to the reported comet assay results obtained using purified
lymphocytes, possibly because whole-blood cultures contain catalase and glutathione peroxidase capable of reduc-
ing the effects of reactive oxygen species.
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Thyroid hormones stimulate development, growth
and metabolism in most vertebrate tissues (Lazar, 2003). At
the molecular level, increased metabolic rate and oxygen
consumption is achieved both by the short-term action of
3,5-didodothyronine on mitochondrial cytochrome oxidase
c and long-term changes of nuclear and mitochondrial gene
transcription mediated by 3,3’,5-triiodothyronine (Goglia
et al., 1999). The molecular mechanisms of thyroid hor-
mone action have been thoroughly investigated but data is
still sparse on possible genotoxic and mutagenic effects.
Although it has been shown that thyroxine (T4) acts as a
co-carcinogen in the development of rat colon cancer (Iishi
et al., 1992) and that prolonged administration of thyroxine
increases gastric carcinogenesis induced by
N-methyl-N‘-nitro-N-nitrosoguanidine in Wistar rats (Iishi
et al., 1993), these effects resulted from non-genotoxic
mechanisms possibly due to the stimulation of cell prolifer-
ation. It is known, however, that thyroid hormones increase
aerobic metabolism in mitochondria and causes intense
production of reactive oxygen and nitrogen species, leading
to the condition of oxidative stress (Venditti et al., 2003;
Fernandez et al., 2005). Moreover, binding of thyroid hor-
mones to specific nuclear receptors in target cells induces
expression of enzymes related to redox processes and the
total rate of oxygen consumption is enhanced
(Oppenheimer et al., 1996). Oxidative stress induced by
thyroid hormones can lead to lipid and protein oxidation in
rat liver cells (Tapia et al., 1999). Experimentally induced
hyperthyroidism in rat liver is accompanied by an increased
rate of hepatic O2 consumption, enhanced microsomal oxi-
dative capacity and the generation of reactive oxygen spe-
cies (ROS) (Fernandez et al., 2003). In addition, treatment
with thyroid hormone decreases the activity of superoxide
dismutase (SOD), catalase and glutathione content in rat
liver (Fernandez et al., 1988). This depression of key
antioxidative mechanisms favors oxidative stress in the
liver (Tapia et al., 1999).
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Short Communication
It is well established that oxidative stress causes dam-
age to biological molecules such as proteins, membrane
lipids and DNA. Oxidative DNA damage can produce a
wide variety of DNA modifications including base and
sugar lesions, strand breaks, DNA-protein cross-links and
base-free sites (Evans et al., 2004). Elevated levels of thy-
roid hormones can enhance production of ROS in mito-
chondria not only in organs under the strong influence of
thyroid status (i.e. the liver), but also in human leukocytes
(Magsino et al., 2000). Indeed, more recent experimental
findings have shown that thyroid hormones induce DNA
damage in human lymphocytes (Djelic and Anderson,
2003) and sperm (Dobrzynska et al., 2004), which can be
observed in the comet assay. Since the antioxidant enzyme
catalase reduced these effects, DNA damage was caused
mainly by action of ROS. In our previous investigations,
we also studied the cytogenetic effects of L-thyroxine on
human peripheral blood lymphocytes by monitoring sis-
ter-chromatid exchange (SCE) and micronuclei as end-
points of the genotoxic exposure (Djelic et al., 2006).
However, thyroxine exhibited only weak genotoxic effects
expressed as an increased frequency of SCE per cell in cul-
tured human lymphocytes, whereas no effect was observed
in the cytokinesis block micronucleus assay (Djelic et al.,
2006). Since these results of cytogenetic evaluation of thy-
roxine toxicity were equivocal, we undertook the investiga-
tion described in this paper to further elucidate possible
clastogenic effects of thyroxine on cultured human lym-
phocytes.
The thyroid hormone L-thyroxine (3-[4-(4-Hydroxy-
3,5-diiodophenoxy)-3,5-diiodophenyl]-l-alanine (or T4),
molecular mass 776.87, CAS No. 51-48-9) was investi-
gated at concentrations ranging from 0.002 μM to 50 μM
(Table 1) dissolved in dimethyl sulfoxide (DMSO). In addi-
tion to untreated cultures, the negative control was 0.8%
(v/v) DMSO (final conc. 0.1 M), without thyroxine, and the
positive control was the mutagen N-methyl-N‘-nitro-N-
nitrosoguanidine (MNNG, CAS No. 70-25-7), without
DMSO, at a concentration of 1 μM. These chemicals were
purchased from the Sigma Chemical Co., St. Louis, USA.
Human peripheral blood lymphocyte cultures were
set up, as previously reported by Djelic et al. (1996), ac-
cording to a slight modification of the protocol described
by Evans and O’Riordan (1975). Briefly, 0.8 mL hepa-
rinized whole blood samples, obtained by venipuncture
from three healthy Caucasian male volunteers under
30 years of age, were added to vials with 9.2 mL of RPMI
1640 media (Gibco, Grand Island, NY) supplemented with
15% (v/v) of heat-inactivated fetal calf serum (Gibco,
Eggenstein, Germany) and supplemented with 1% (w/v)
penicillin, 1% (w/v) streptomycin (Galenika, Belgrade,
Serbia) and 5 μg mL-1 of phytohemagglutinin (Murex Di-
agnostics Ltd., Dartford, England). Duplicate cultures from
each donor were incubated in the dark for 72 h at 37 °C. The
study was approved by the local Medical Ethics Commit-
tee, performed in accordance with the Declaration of
Helsinki, and informed donor consent was also obtained.
Two L-thyroxine exposure times were used (24 h and
48 h), appropriate concentrations (0.002 μM to 50 μM, Ta-
ble 1) of L-thyroxine dissolved in DMSO being added to
the culture vials after 24 h incubation for the 48 h exposure
experiment and at 48 h for the 24 h exposure experiment.
Two hours before harvesting 0.5 μg mL-1 colcemid
(Ciba, Basel, Switzerland) was added to the cultures and
the cells treated with hypotonic 0.075 M KCl. After three
standard cycles of fixation in methanol/acetic acid (3:1,
v/v) the cell suspension was dropped onto chilled grease-
free coded microscopic slides, air dried and stained in 5%
(v/v) Giemsa (Merck, Darmstadt, Germany). We scored
200 mitotic plates per donor (100 per each duplicate cul-
ture) for each experimental concentration and for the posi-
tive and negative controls. Scoring of gaps and breaks was
performed according to Brogger (1982) and the mitotic in-
dex (MI) was calculated as the percentage of cells in mito-
sis based on at least 2000 cells per donor.
Statistical analysis of cytogenetic endpoints and mi-
totic index was carried out using the chi-squared (χ2) test
(Sivikova et al., 1999) at a significance level of p = 0.05 or
lower.
In addition to the cytogenetic analysis we monitored
possible cytotoxic or mitogenic effects of thyroxine using
the analysis of the mitotic index on the same slides, the re-
sults for both types of analysis being shown in Table 1.
To evaluate the possible clastogenic effects of L-thy-
roxine we analyzed cultured whole-blood lymphocytes for
chromosome lesions (gaps and breaks), rearrangements
and numeric and structural aberrations, but we found no
statistically significant structural chromosome aberrations
after treatment with L-thyroxine dissolved in DMSO when
compared to the negative control lymphocytes exposed to
DMSO only, nor in comparison to untreated cultures, even
though various types of chromosome lesions were detected
and carefully scored by three independent assessors
(Table 1). Thus, the overall percentage of aberrant cells in
L-thyroxine treated cultures was in the range of 0% to 4.5%
and there was no significant departure (p > 0.05) form the
negative control base level. This agrees with our previous
investigations (Djelic et al., 2006) in which we observed no
significant effect in the cytokinesis block micronucleus as-
say, using blood samples from the same donors and the
same assay conditions. As expected, the positive control
(MNNG) caused significant clastogenic effects, detectable
as an increase in breaks and chromatid and isochromatid
exchanges (p < 0.001), indicating that the experimental
conditions were suitable for detecting clastogenic effects.
After 24 h exposure the mean mitotic index was 5.5%
for the negative control lymphocytes from all three donors.
The experimental mitotic index values for cultures exposed
to L-thyroxine for 24 h ranged from 2.4% to 6.1%. The
highest concentration (50 μM) of L-thyroxine caused a sig-
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nificant decrease in mitotic index compared to the value of
the negative control. Furthermore, at concentrations of
15 μM the mitotic index was still significantly decreased
for the lymphocytes from donor 1 (p < 0.01) and donor 3
(p < 0.001), whereas for donor 2 although there was a de-
crease in the mitotic index at this concentration the de-
crease was not significant. After 48 h exposure the mean
mitotic index for the negative control lymphocytes from the
three donors was 3.5% , whereas the overall range in cul-
tures treated with L-thyroxine was from 1.7% to 4.1%. The
two highest L-thyroxine concentrations (15 μM and
50 μM) caused a significant decrease of mitotic index in the
lymphocytes from all three donors at 48 h (Table 1). How-
ever, these concentrations far exceed not only the normal
blood thyroxine level (~0.1 μM) and level in L-thyroxine
treated patients, but also L-thyroxine level both in severe
hyperthyroidism (Ganong, 1995) and acute L-thyroxine
overdose (Berkner et al., 1991). As expected, the positive
control significantly lowered the mitotic index values for
the lymphocytes from all three donors, both after 24 h and
48 h of exposure (Tables 1).
Investigations in the field of genetic toxicology have
mainly concentrated on environmental pollutants, most of
which result from intense development of chemical and
other industries (Pitarque et al., 2002; Stanimirovic et al.,
2005). However, there is increasing evidence that sub-
stances which are normally present in human or animal
bodies may, under the certain circumstances, exhibit dele-
terious effects on genetic material and therefore act as en-
dogenous mutagenic agents (Lutz, 1990; Totsuka et al,
2005).
One of the best studied group of endogenous muta-
genic agents are estrogenic hormones (Anderson et al.,
2003; Schallreuter et al., 2006). It is well established that
metabolic conversion of phenolic estrogen moieties accom-
panied by the generation of ROS leads to covalent damage
of cellular macromolecules including DNA (Liehr, 2001;
Li et al., 2004). Interestingly, there are some experimental
indications that phenolic groups of some non-steroid hor-
mones (adrenaline, thyroid hormones) and neurotransmit-
ters (dopamine, noradrenaline) may undergo redox cycling
accompanied by the generation of ROS which favor oxida-
tive stress (Moldeus et al., 1983; Djelic and Anderson,
2003; Dobrzynska et al., 2004). It thus seems that oxidative
stress is the key mechanism of the genotoxic effects of both
steroid and non-steroid hormones with phenolic groups.
The comet assay has shown that thyroid hormones
can cause in vitro DNA damage to purified human lympho-
cytes (Djelic and Anderson, 2003) and sperm (Dobrzynska
et al, 2004) and that the damage can be reduced by the anti-
oxidant enzyme catalase, indicating that the genotoxic ef-
fects of thyroid hormones may be principally due to ROS.
The suggestion that L-thyroxine can have genotoxic effects
is supported by reports of increased SCE in human lympho-
cytes treated with relatively high concentrations of L-thy-
roxine, although since L-thyroxine did not induce micro-
nuclei under the same experimental conditions the
cytogenetic effects of L-thyroxine were unclear (Djelic et
al., 2006). It is important to note, however, that in the study
by Djelic and Anderson (2003) the DNA damage attributed
to thyroid hormones was detected by the comet assay of pu-
rified human lymphocytes, with the cytogenetic evaluation
of the genotoxic effects of L-thyroxine on lymphocytes
from whole blood cultures producing equivocal results.
These discrepancies may be explained, at least in part, by
the findings of Andreoli et al. (1999) who reported more se-
vere genotoxic effects on purified lymphocytes than com-
pared to lymphocytes from whole-blood cultures, probably
because erythrocytes in whole blood contain catalase and
glutathione peroxidase which eliminate hydrogen peroxide
and reduce the amount of ROS available for generating
DNA damage.
Our results show that L-thyroxine did not produce
clastogenic effects which could be detected on the basis of
cytogenetic analysis and supports previous observations
that L-thyroxine does not cause any significant increase in
the micronucleus frequency of human peripheral blood
lymphocytes (Djelic et al., 2006). However, it should be
pointed out that thyroid hormones caused DNA damage in
the comet assay, at high concentrations in a range
10-100 μM (Djelic and Anderson, 2003; Dobrzynska et al,
2004). Although these concentrations are comparable with
two highest concentrations of L-thyroxine in the present
study, genotoxic effects were observed only in the comet
assay, which is more sensitive in comparison to the cyto-
genetic analysis.
Analysis of clastogenic effects has not revealed any
significant difference between untreated cultures and nega-
tive controls treated with DMSO (Table 1), as observed
previously by de Lima et al. (2005). Also, there was no sig-
nificant response in thyroxine-treated cultures, in compari-
son to both untreated and DMSO treated cultures.
The percentage of cells in mitosis was significantly
decreased only at two highest L-thyroxine concentrations,
possibly due to cytotoxic effects. This finding is in accor-
dance with our previous cytogenetic study (Djelic et al.,
2006) in which we observed decreases in mitotic index at
the same experimental concentrations of L-thyroxine. As
expected, positive control caused a more profound decrease
in mitotic index, possibly due to arrested mitosis as a result
of the repair of genetic damage or cytotoxic effects due to
relatively high levels of genetic damage.
The results indicate that normal levels of L-thyroxine
do not produce clastogenic effects on human lymphocytes
in whole-blood cultures. In this investigation, the concen-
tration of L-thyroxine of 0.15 μM corresponds to the total
plasma level in euthyroid persons (Ganong, 1995). The
higher concentration of 1.5 μM exceeds the total serum
L-thyroxine concentration in Graves disease, but it is com-
parable to L-thyroxine blood level in an acute overdose
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(Berkner et al., 1991). Although L-thyroxine can increase
the SCE rate (Djelic et al. 2006), the molecular mecha-
nisms of SCE formation and their biological significance
are not clear. Furthermore, the SCE test only indicates ex-
posure to genotoxins, while the chromosome aberration
and micronucleus assays are mutagenicity tests (Speit and
Henderson, 2005) and are therefore of more significance
than the SCE test. Based on these results we conclude that,
under the experimental conditions employed in this study,
L-thyroxine does not exhibit cytogenetically detectable
genotoxic effects in lymphocytes from whole-blood cul-
tures.
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